Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001023024-25-000046
Filing Date
2025-05-09
Accepted
2025-05-09 06:57:59
Documents
100
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q anip-20250331.htm   iXBRL 10-Q 1514084
2 EX-31.1 anip-20250331x10qxexx311.htm EX-31.1 10309
3 EX-31.2 anip-20250331x10qxexx312.htm EX-31.2 9838
4 EX-32.1 anip-20250331x10qxexx321.htm EX-32.1 7019
  Complete submission text file 0001023024-25-000046.txt   10507329

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anip-20250331.xsd EX-101.SCH 85390
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT anip-20250331_cal.xml EX-101.CAL 102300
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anip-20250331_def.xml EX-101.DEF 510138
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT anip-20250331_lab.xml EX-101.LAB 971897
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anip-20250331_pre.xml EX-101.PRE 730211
103 EXTRACTED XBRL INSTANCE DOCUMENT anip-20250331_htm.xml XML 1420724
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 25928303
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)